To comprehensively evaluate the therapeutic effects of semaglutide on hepatic steatosis, future studies should incorporate complementary methods such as Oil Red O staining (Zhu et al., 2019), biochemical hepatic TG assays (Rong et al., 2024), or non-invasive imaging techniques such as magnetic resonance imaging with proton density fat fraction (MRI-PDFF) (Park et al., 2022)
This exclusion applies to all GLP-1 medications, including Wegovy, when prescribed for obesity
This drug may cause side effects, including nausea/vomiting, change in bowel movements, including diarrhea or constipation, abdominal pain, headache, and fatigue
Standard Lipo C Dosage Protocols and Titration Most clinics begin with 1mL weekly administered subcutaneously in the abdomen or intramuscularly in the deltoid or gluteal region
Wegovy may cause serious side effects, including: Possible thyroid tumors , including cancer